Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Comment by MustangSalleyon Jun 15, 2021 2:18pm
106 Views
Post# 33389492

RE:RE:Nice Device , thanks Canada

RE:RE:Nice Device , thanks Canada

Redbaron2211 wrote: Mustang Sally anything preclinical is not competition. You can add it to the massive pile of maybes. I'm not rushing into voting the bod off I encourage others to think it through.

 


it is preclinical I agree, but if Vertex buys them it won't be that long while Tolekis tries to figure things out .  Vertex will throw money at it and have experienced management and clinical team to follow through . Yes Sva has a head start but for how long ?


Anybody is free to vote as they wish.  Like I said get the sp to $2 and some liquidity and I will be gone forever from this board .

Agm is going to be a repeat of February news conference , more promises and 6 months later nothing .

I could be wrong and trust me I would like to move on and get out of this great disruptive clinical device for regenerative medicine but unfortunately with inexperienced , incompetent management .

Mrs Sally 

<< Previous
Bullboard Posts
Next >>